Element Genomics was a Duke-founded biotechnology startup established in 2015 to develop computational tools and CRISPR-based approaches for understanding gene regulation. Based in Durham, North Carolina, the company was subsequently acquired by UCB to strengthen its research capabilities.
Subscribe to see Element Genomics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Element Genomics, Inc. is a biotech company headquartered in United States. Its most recent funding round, Series A, raised $4.8M in November 2016. Xcout tracks 15 named people at Element Genomics, Inc., including Logan Zinser (CFO). Xcout recorded 29 job postings from Element Genomics, Inc. in the last 90 days.
9 more named people on record for Element Genomics, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $4.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 29 job postings from Element Genomics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Element Genomics, Inc.'s hiring signals →
A few of Element Genomics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Enhanced Genomics Ltd. is a functional genomics company headquartered in Cambridge, United Kingdom. The firm utilizes its proprietary 3D multi-omics genomics technology to uncover causal biology behind genetic variation and transform drug target discovery.
Fauna Bio is a biotechnology company headquartered in Berkeley, California. The company combines animal genomics and advanced data approaches to drive drug discovery and improve human health.
Variant Bio, Inc. is a biotechnology company that uses human genomic diversity and population genetics to discover therapeutic targets and develop medicines. It works with researchers, healthcare and biotechnology partners, and genetically diverse communities to study traits associated with health and disease.
Broken String Biosciences is a biotechnology research company headquartered in Cambridge, England, operating out of Little Chesterford. The company develops advanced platforms dedicated to powering the future of gene editing safety and development.
Shift Bioscience is a biotechnology research company based in Cambridge, United Kingdom, that employs generative AI virtual cell models to understand gene activation and cellular reprogramming.
Verge Genomics develops a proprietary AI and machine learning platform utilizing human brain data to transform neuroscience drug discovery and precision neurology. The company provides foundation models and analytical tools to pharmaceutical and biotechnology developers for target discovery, biomarker identification, and clinical trial patient stratification.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.